Cargando…

Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma

Lung cancer is one of the most common malignant neoplasms. As a result of the disease’s progression, patients may develop metastases to the central nervous system. The prognosis in this location is unfavorable; untreated metastatic lesions may lead to death within one to two months. Existing therapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rybarczyk-Kasiuchnicz, Agnieszka, Ramlau, Rodryg, Stencel, Katarzyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826874/ https://www.ncbi.nlm.nih.gov/pubmed/33435596 http://dx.doi.org/10.3390/ijms22020593

Ejemplares similares

Current views on molecularly targeted therapy for lung cancer – a review of literature from the last five years
por: Rybarczyk-Kasiuchnicz, Agnieszka, et al.
Publicado: (2018)

Anti-angiogenic agents in the treatment of non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

Non-Small-Cell Lung Cancer: New Rare Targets—New Targeted Therapies—State of The Art and Future Directions
por: Stencel, Katarzyna, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy in Non-Small Cell Lung Cancer—Clinical Trials Experience
por: Chmielewska, Izabela, et al.
Publicado: (2021)

Actual status of therapeutic vaccination in non-small cell lung cancer
por: Szyszka-Barth, Katarzyna, et al.
Publicado: (2014)

Erlotinib in salvage treatment of patients with advanced non-small cell lung cancer: results of an expanded access programme in Poland
por: Kowalski, Dariusz M., et al.
Publicado: (2012)

Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy
por: Grodzka, Anna, et al.
Publicado: (2023)

Systemic treatment of non-small cell lung cancer brain metastases
por: Cedrych, Ida, et al.
Publicado: (2016)

Brain metastases from non-small cell lung carcinoma: an overview of classical and novel treatment strategies
por: Martin, Margarita, et al.
Publicado: (2022)

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy
por: Hirsh, Vera, et al.
Publicado: (2007)

The comparison of acute toxicity in 2 treatment courses: Three-weekly and weekly cisplatin treatment administered with radiotherapy in patients with head and neck squamous cell carcinoma
por: Mackiewicz, Jacek, et al.
Publicado: (2017)

Immune checkpoint inhibitors for the treatment of non-small cell lung cancer brain metastases
por: Wei, Yuxi, et al.
Publicado: (2023)

Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer
por: Thomas, Sayana R, et al.
Publicado: (2007)

The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma
por: Krawczyk, Paweł, et al.
Publicado: (2013)

Cystic brain metastases in ALK-rearranged non-small cell lung cancer
por: Marta, Guilherme Nader, et al.
Publicado: (2018)

Methods and results of locoregional treatment of brain metastases in patients with non-small cell lung cancer
por: Patla, Anna, et al.
Publicado: (2016)

Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases
por: Jubb, A M, et al.
Publicado: (2011)

The Management of Brain Metastases in Non-Small Cell Lung Cancer
por: Owen, Scott, et al.
Publicado: (2014)

Impact of copy number variant and single nucleotide polymorphism of the programmed death-ligand 1 gene, programmed death-ligand 1 protein expression and therapy regimens on overall survival in a large group of Caucasian patients with non-small cell lung carcinoma
por: Grenda, Anna, et al.
Publicado: (2021)

The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
por: Wojas-Krawczyk, Kamila, et al.
Publicado: (2013)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer
por: Jablonska, Paola Anna, et al.
Publicado: (2021)

Surgical Treatment of Non-Small Cell Lung Cancer with Isolated Synchronous Brain Metastases
por: I, Hoseok, et al.
Publicado: (2006)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

The Immune Microenvironment in Brain Metastases of Non-Small Cell Lung Cancer
por: Luo, Lumeng, et al.
Publicado: (2021)

State-of-the-art considerations in small cell lung cancer brain metastases
por: Lukas, Rimas V., et al.
Publicado: (2017)

Immunotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: Clinical Challenges and Future Directions
por: Pathak, Ranjan, et al.
Publicado: (2021)

Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
por: De Carlo, Elisa, et al.
Publicado: (2022)

Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion
por: Preusser, Matthias, et al.
Publicado: (2018)

Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer
por: Nian, Rui, et al.
Publicado: (2022)

The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategies
por: Wierzbicka, Małgorzata, et al.
Publicado: (2015)

Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer
por: Xu, Yi-Bing, et al.
Publicado: (2021)

Brain Metastases in Oncogene-Addicted Non-Small Cell Lung Cancer Patients: Incidence and Treatment
por: Remon, J., et al.
Publicado: (2018)

Crizotinib in the treatment of non-small-cell lung carcinoma
por: Płużański, Adam, et al.
Publicado: (2013)

Radiotherapy in brain metastases from EGFR-mutated non-small cell lung cancer
por: Bhandari, Shruti, et al.
Publicado: (2021)

Risk factors for brain metastases in patients with non–small‐cell lung cancer
por: An, Ning, et al.
Publicado: (2018)

Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases
por: Huang, Richard S P, et al.
Publicado: (2022)

The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients
por: Michalak, Slawomir, et al.
Publicado: (2016)

Fertility Counseling in BRCA1/2-Mutated Women with Breast Cancer and Healthy Individuals
por: Kufel-Grabowska, Joanna, et al.
Publicado: (2022)

A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives
por: Sulewska, Anetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sebkf7dbm1qoh3iovh3bdd2474